European Journal of Cancer
Volume 45, Issue 10 , Pages 1824-1830 , July 2009

Genetic variation in sodium-dependent ascorbic acid transporters and risk of gastric cancer in Poland

  • Margaret E. Wright

      Affiliations

    • Department of Pathology, University of Illinois at Chicago, 840 S Wood St., CSN 130, Chicago, IL 60612, USA
    • Corresponding Author InformationCorresponding author: Tel.: +1 312 996 9684; fax: +1 312 996 4812.
    • ,
  • Gabriella Andreotti

      Affiliations

    • Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD 20892, USA
    • ,
  • Jolanta Lissowska

      Affiliations

    • Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, 02-781 Warsaw, Poland
    • ,
  • Meredith Yeager

      Affiliations

    • Core Genotyping Facility, Advanced Technology Center, National Cancer Institute, NIH, DHHS, Gaithersburg, MD 20892, USA
    • ,
  • Witold Zatonski

      Affiliations

    • Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, 02-781 Warsaw, Poland
    • ,
  • Stephen J. Chanock

      Affiliations

    • Core Genotyping Facility, Advanced Technology Center, National Cancer Institute, NIH, DHHS, Gaithersburg, MD 20892, USA
    • ,
  • Wong-Ho Chow

      Affiliations

    • Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD 20892, USA
    • ,
  • Lifang Hou

      Affiliations

    • Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA

Received 5 December 2008 ,Revised 15 January 2009 ,Accepted 22 January 2009.

References 

  1. Ferlay J, Bray F, Pisani P, Parkin D. GLOBOCAN 2002: cancer incidence, mortality, and prevalence worldwide: IARC cancerbase no. 5 (version 2.0). Lyon: IARC Press; 2004.
  2. Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer. 2008;44(10):1345–1389
  3. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington DC: AICR; 2007.
  4. Shils ME, Shike M, Ross AC, Caballero B, Cousins RC. Modern nutrition in health and disease. 10th ed.. Philadelphia: Lippincott Williams & Wilkins; 2006;
  5. Jarosz M, Dzieniszewski J, Dabrowska-Ufniarz E, Wartanowicz M, Ziemlanski S, Reed PI. Effects of high dose vitamin C treatment on Helicobacter pylori infection and total vitamin C concentration in gastric juice. Eur J Cancer Prev. 1998;7(6):449–454
  6. Schorah CJ, Sobala GM, Sanderson M, Collis N, Primrose JN. Gastric juice ascorbic acid: effects of disease and implications for gastric carcinogenesis. Am J Clin Nutr. 1991;53(1 Suppl):287S–293S
  7. Sobala GM, Schorah CJ, Sanderson M, et al. Ascorbic acid in the human stomach. Gastroenterology. 1989;97(2):357–363
  8. Waring AJ, Drake IM, Schorah CJ, et al. Ascorbic acid and total vitamin C concentrations in plasma, gastric juice, and gastrointestinal mucosa: effects of gastritis and oral supplementation. Gut. 1996;38(2):171–176
  9. Wilson JX. Regulation of vitamin C transport. Annu Rev Nutr. 2005;25:105–125
  10. Tsukaguchi H, Tokui T, Mackenzie B, et al. A family of mammalian Na+-dependent l-ascorbic acid transporters. Nature. 1999;399(6731):70–75
  11. Eck P, Erichsen HC, Taylor JG, et al. Comparison of the genomic structure and variation in the two human sodium-dependent vitamin C transporters, SLC23A1 and SLC23A2. Hum Genet. 2004;115(4):285–294
  12. Chow WH, Swanson CA, Lissowska J, et al. Risk of stomach cancer in relation to consumption of cigarettes, alcohol, tea and coffee in Warsaw, Poland. Int J Cancer. 1999;81(6):871–876
  13. Block G, Hartman AM, Naughton D. A reduced dietary questionnaire: development and validation. Epidemiology. 1990;1(1):58–64
  14. Los-Kuczera M. Food composition tables (in Polish). Warsaw: National Food and Nutrition Institute; 1990;
  15. United States Department of Agriculture, Agricultural Research Service. Composition of foods: raw, processed, prepared. USDA Agriculture Handbook No. 8. Washington, DC: USDA; 1990.
  16. Sherry ST, Ward M, Sirotkin K. DbSNP-database for single nucleotide polymorphisms and other classes of minor genetic variation. Genome Res. 1999;9(8):677–679
  17. Packer BR, Yeager M, Burdett L, et al. SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res. 2006;34(Database issue):D617–D621
  18. Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. Washington, DC: National Academy Press; 2000.
  19. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21(2):263–265
  20. Lake SL, Lyon H, Tantisira K, et al. Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered. 2003;55(1):56–65
  21. Schaid DJ. Evaluating associations of haplotypes with traits. Genet Epidemiol. 2004;27(4):348–364
  22. Lissowska J, Gail MH, Pee D, et al. Diet and stomach cancer risk in Warsaw, Poland. Nutr Cancer. 2004;48(2):149–159
  23. Vainio H, Bianchini F IARC Working Group on the Evaluation of Cancer-Preventive Strategies. Fruit and vegetables. IARC handbooks of cancer prevention. vol. 8. Lyon: IARC Press; 2003;
  24. Liu C, Russell RM. Nutrition and gastric cancer risk: an update. Nutr Rev. 2008;66(5):237–249
  25. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Systematic review and meta-analysis: primary and secondary prevention of gastrointestinal cancers with antioxidant supplements. Aliment Pharmacol Ther. 2008;28:689–703
  26. Meyskens FL, Szabo E. Diet and cancer: the disconnect between epidemiology and randomized clinical trials. Cancer Epidemiol Biomarkers Prev. 2005;14(6):1366–1369
  27. Drake IM, Davies MJ, Mapstone NP, et al. Ascorbic acid may protect against human gastric cancer by scavenging mucosal oxygen radicals. Carcinogenesis. 1996;17(3):559–562
  28. Mirvish SS. Experimental evidence for inhibition of N-nitroso compound formation as a factor in the negative correlation between vitamin C consumption and the incidence of certain cancers. Cancer Res. 1994;54(7 Suppl.):1948s–1951s
  29. Oliveira CP, Kassab P, Lopasso FP, et al. Protective effect of ascorbic acid in experimental gastric cancer: reduction of oxidative stress. World J Gastroenterol. 2003;9(3):446–448
  30. Zhang ZW, Abdullahi M, Farthing MJ. Effect of physiological concentrations of vitamin C on gastric cancer cells and Helicobacter pylori. Gut. 2002;50(2):165–169
  31. Zhang HM, Wakisaka N, Maeda O, Yamamoto T. Vitamin C inhibits the growth of a bacterial risk factor for gastric carcinoma: Helicobacter pylori. Cancer. 1997;80(10):1897–1903

PII: S0959-8049(09)00054-9

doi: 10.1016/j.ejca.2009.01.027

European Journal of Cancer
Volume 45, Issue 10 , Pages 1824-1830 , July 2009

Article Tools